StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 86.11 B
Share Price
USD 177.62
Avg Daily Volume
834,388
Change (1 day)
1.34%
Change (1 year)
-13.05%
Change (YTD)
1.92%
CSL Limited Shares (Diluted, Weighted) for the year ending June 30, 2024: 485,199,307
CSL Limited Shares (Diluted, Weighted) is 485,199,307 for the year ending June 30, 2024, a 0.27% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
CSL Limited Shares (Diluted, Weighted) for the year ending June 30, 2023 was 483,886,450, a 2.93% change year over year.
-
CSL Limited Shares (Diluted, Weighted) for the year ending June 30, 2022 was 470,117,188, a 3.05% change year over year.
-
CSL Limited Shares (Diluted, Weighted) for the year ending June 30, 2021 was 456,203,803, a 0.13% change year over year.
-
CSL Limited Shares (Diluted, Weighted) for the year ending June 30, 2020 was 455,605,010, a 0.35% change year over year.
Competitors
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
Revvity, Inc.
USD 101.97
RVTY
+2.52
2.53%
Syngene International Limited
USD 7.89
SYNGENE.NS
+0.14
1.86%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.38
002317.SZ
+0.01
0.43%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.86
688321.SS
-0.03
-0.58%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
Key Data
| Date | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue |
|---|
Competitors
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
Revvity, Inc.
USD 101.97
RVTY
+2.52
2.53%
Syngene International Limited
USD 7.89
SYNGENE.NS
+0.14
1.86%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.38
002317.SZ
+0.01
0.43%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.86
688321.SS
-0.03
-0.58%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%